CDT Equity Inc. Announces Reverse Stock Split

Core Viewpoint - CDT Equity Inc. has announced a 1-for-8 reverse stock split aimed at increasing the funds available for executing its strategic initiatives [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect on October 10, 2025, at 5:00 PM Eastern Time, with trading on a reverse-adjusted basis starting on October 13, 2025 [2]. - Every eight shares of the Company's common stock will be combined into one share, maintaining a par value of $0.0001 per share [3]. - The number of outstanding shares will be reduced to approximately 1,352,448, and no fractional shares will be issued; stockholders entitled to fractional shares will receive a cash payment [4]. Group 2: Stockholder and Trading Information - The Company's transfer agent, VStock Transfer, LLC, will manage the exchange process, and registered stockholders will not need to take action to receive their new shares [5]. - The common stock will continue to trade under the ticker symbol "CDT" with a new CUSIP number of 20678X403 following the reverse stock split [4]. Group 3: Company Overview - CDT Equity Inc. is a biopharmaceutical development company focused on advancing therapeutic assets through scientific innovation and strategic partnerships [6]. - The company leverages artificial intelligence and solid-form chemistry to accelerate the development of novel treatments, aiming to create shareholder value through licensing and strategic mergers and acquisitions [6].